Related Experiment Video
Updated: May 13, 2026
09:16
Oligopeptide Competition Assay for Phosphorylation Site Determination
Published on: May 18, 2017
Advances in the development of AMPK-activating compounds.
Apiradee Sriwijitkamol1, Nicolas Musi
1University of Texas Health Science Center at San Antonio, Diabetes Division, San Antonio, Texas, USA.
Expert Opinion on Drug Discovery
|March 16, 2013
Summary
AMP-activated protein kinase (AMPK) regulates metabolism. Activating AMPK with compounds like AICAR shows promise for treating type 2 diabetes and high cholesterol by improving glucose and lipid metabolism.
Area of Science:
- Biochemistry
- Metabolic Research
- Pharmacology
Background:
- AMP-activated protein kinase (AMPK) is a critical enzyme in energy sensing.
- It plays a key role in regulating both glucose and lipid metabolism.
Purpose of the Study:
- To review current data on AMPK as a potential drug target.
- Focus on its application in treating metabolic disorders.
Main Methods:
- Briefly reviewed mechanisms of AMPK activity.
- Examined AMPK's control over various metabolic pathways.
- Detailed the effects of AMPK activators on glucose metabolism.
Main Results:
- AMPK activation promotes glucose transport in skeletal muscles.
- AMPK inhibits glucose production in the liver.
- AICAR (AMPK activator) enhances fatty acid oxidation and reduces liver cholesterol synthesis.
Conclusions:
- AMPK's metabolic effects suggest it's a viable target for type 2 diabetes and hypercholesterolemia.
- Ongoing research with novel AMPK activators will determine its therapeutic potential and safety in humans.
Related Concept Videos
01:25cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
02:54Protein Kinases and Phosphatases
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...